Cytokine Response of the Biomimetic Porcine Urothelial Model to Different Escherichia coli Strains
Source abstract
Abstract
Escherichia coli is known to be an important uropathogenic agent. Several models were developed for investigating the uropathogensis of E. coli, including the recent biomimetic porcine urothelial in vitro model. The aim of this study was to assess the cytokine response of the cells of the biomimetic porcine urothelial model to different E. coli strains. The production of nine different cytokines in response to E. coli infection was evaluated using the commercial pre-configured immunoassay multiplex Cytokine & Chemokine 9-Plex Porcine ProcartaPlex™ Panel 1 kit. Our results showed that cells of the biomimetic porcine urothelial model reacted to the presence of all the employed different E. coli strains, albeit with some differences in levels and types of cytokines produced. Increased production of IL-10, IL-8, TNF-α, IL-1β, IL-4 and IL-12p40 was observed. Statistical analysis (Fisher’s exact test) revealed a correlation between the high fold change in the immune response and the presence of the cnf1 gene that encodes the cytotoxic necrotizing factor. Our results shed light on the cytokine response of normal urothelial cells to different E. coli strains and have the potential to fuel the search for understanding the mechanisms behind the different cytokine responses to different E. coli strains.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Urinary Tract Infections Management · Escherichia coli research studies · Gut microbiota and health
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
Funding
Slovenian Research Agency
References (46)
Show source-provided references
1. Recent advances in understanding enteric pathogenic Escherichia coli10.1128/CMR.00022-13 ↗
2. Pathogenic Escherichia coli10.1038/nrmicro818 ↗
3. Difference in the regulation of IL-8 expression induced by uropathogenic E. coli between two kinds of urinary tract epithelial cells10.1186/1423-0127-16-91 ↗
4. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism10.4049/jimmunol.166.2.1148 ↗
5. Rapid bladder interleukin-10 synthesis in response to uropathogenic Escherichia coli is part of a defense strategy triggered by the major bacterial flagellar filament FliC and contingent on TLR510.1128/mSphere.00545-19 ↗
6. Predojević, L., Keše, D., Žgur Bertok, D., Železnik Ramuta, T., Veranič, P., Erdani Kreft, M., and Starčič Erjavec, M. (2022). A biomimetic porcine urothelial model for assessing Escherichia coli pathogenicity. Microorganisms, 10.10.3390/microorganisms10040783 ↗
7. Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance10.1007/s00418-011-0893-0 ↗
8. The complete functional recovery of chitosan-treated biomimetic hyperplastic and normoplastic urothelial models10.1007/s00418-014-1265-3 ↗
9. Chitosan hydrochloride has no detrimental effect on bladder urothelial cancer cells10.1016/j.tiv.2017.08.008 ↗
10. Triple labelling of actin filaments, intermediate filaments and microtubules for broad application in cell biology: Uncovering the cytoskeletal composition in tunneling nanotubes10.1007/s00418-019-01806-3 ↗
11. Differentiation-dependent rearrangements of actin filaments and microtubules hinder apical endocytosis in urothelial cells10.1007/s00418-017-1566-4 ↗
12. Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells10.1007/s00418-017-1605-1 ↗
13. Ramuta, T., Tratnjek, L., Janev, A., Seme, K., Starčič Erjavec, M., and Kreft, M.E. (2021). The antibacterial activity of human amniotic membrane against multidrug-resistant bacteria associated with urinary tract infections: New insights from normal and cancerous urothelial models. Biomedicines, 9.10.3390/biomedicines9020218 ↗
14. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: Evidence from in vitro FimH binding10.1242/jcs.114.22.4095 ↗
15. Uroplakin traffic through the Golgi apparatus induces its fragmentation: New insights from novel in vitro models10.1038/s41598-017-13103-x ↗
16. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups10.1007/s00284-005-0501-4 ↗
17. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin10.1099/jmm.0.2008/002543-0 ↗
18. Prevalence and associations of tcpC, a gene encoding a Toll/interleukin-1 receptor domain-containing protein, among Escherichia coli urinary tract infection, skin and soft tissue infection, and commensal isolates10.1128/JCM.01227-09 ↗
19. Hrovat, K., Draganjec, N., and Starčič Erjavec, M. (2014, January 19). A tool for the Fisher’s exact test. Proceedings of the Genetics, 4th Colloquium of Genetics, Piran, Slovenia.
20. Virulence potential for extraintestinal infections among commensal Escherichia coli isolated from healthy humans--the Trojan horse within our gut
21. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection10.4049/jimmunol.1101231 ↗
22. Activation of the NLRP3 inflammasome pathway by uropathogenic Escherichia coli is virulence factor-dependent and influences colonization of bladder epithelial cells10.3389/fcimb.2018.00081 ↗
23. Primary prevention of asthma: From risk and protective factors to targeted strategies for prevention10.1016/S0140-6736(20)31861-4 ↗
24. IL-4: Role in disease and regulation of production10.1046/j.1365-2249.1998.00690.x ↗
25. Insights into the initiation of type 2 immune responses10.1111/j.1365-2567.2011.03499.x ↗
26. Cytokine responses during mucosal infections: Role in disease pathogenesis and host defence10.1016/S1369-5274(99)80017-4 ↗
27. P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract10.1046/j.1462-5822.2001.00111.x ↗
28. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli10.1128/IAI.73.7.3999-4006.2005 ↗
29. The significance of interleukin 8 in urine10.1136/adc.85.3.256 ↗
30. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice10.1128/iai.46.3.839-844.1984 ↗
31. The innate immune response during urinary tract infection and pyelonephritis10.1007/s00467-013-2513-9 ↗
32. Protein-based profiling of the immune response to uropathogenic Escherichia coli in adult patients immediately following hospital admission for acute cystitis10.1093/femspd/ftw062 ↗
33. Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an in vitro interstitial cystitis/bladder pain syndrome model10.3389/fimmu.2022.960667 ↗
34. The immunobiology of the interleukin-12 family: Room for discovery10.1016/j.immuni.2019.03.011 ↗
35. Type-I interferon responses: From friend to foe in the battle against chronic viral infection10.3389/fimmu.2016.00609 ↗
36. Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases10.1515/bmc-2018-0007 ↗
37. Elevated urine IL-10 concentrations associate with Escherichia coli persistence in older patients susceptible to recurrent urinary tract infections10.1186/s12979-019-0156-9 ↗
38. Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections10.1128/jcm.25.1.146-149.1987 ↗
39. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli10.1128/IAI.69.6.3954-3964.2001 ↗
40. Urovirulence determinants in Escherichia coli strains causing prostatitis10.1086/514065 ↗
41. Pushing the limits of cellular microbiology: Microarrays to study bacteria-host cell intimate contacts10.1073/pnas.010505497 ↗
42. Rho GTPase signaling in inflammation and transformation10.1385/IR:21:2-3:103 ↗
43. Cytotoxic necrotizing factor 1 enhances reactive oxygen species-dependent transcription and secretion of proinflammatory cytokines in human uroepithelial cells10.1128/IAI.71.7.4178-4181.2003 ↗
44. Yadav, M., Zhang, J., Fischer, H., Huang, W., Lutay, N., Cirl, C., Lum, J., Miethke, T., and Svanborg, C. (2010). Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog., 6.10.1371/journal.ppat.1001120 ↗
45. The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: Progress and perspectives10.2217/fmb.12.131 ↗
46. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells10.1038/35015091 ↗